London
United Kingdom
8
2025-07-24
2
2022-03-29
These are the the leading inventors for applications assigned to PHAIM PHARMA LTD:
PHAIM PHARMA LTD based in London, GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Diabetes Biomarkers
#2 | 2024-10-31Psoriasis and Other Autoimmune Diseases Antigen Immune Modulator (AIM) Therapeutic Platform
#3 | 2024-09-26Immunomodulatory Therapy For Type 1 Diabetes Mellitus Autoimmunity
#4 | 2023-10-19Diabetes Biomarkers
#5 | 2021-12-30PSORIASIS AND OTHER AUTOIMMUNE DISEASES ANTIGEN IMMUNE MODULATOR (AIM) THERAPEUTIC PLATFORM
#6 | 2021-11-18IMMUNOMODULATORY THERAPY FOR TYPE 1 DIABETES MELLITUS AUTOIMMUNITY
#7 | 2019-07-11 ✅ Patent 11,286,303 granted on 2022-03-29CTLA4 fusion proteins for the treatment of diabetes
#8 | 2016-12-15 ✅ Patent 11,040,093 granted on 2021-06-22Immunomodulatory therapy for type 1 diabetes mellitus autoimmunity
Also check out Phaim Pharma Ltd's (London, United Kingdom) applicant profile with 5 patent applications submitted.
317314 ⎘